Series date: 
10/01/2022 - 7:00am EDT to 12/27/2023 - 8:30am EST

COURSE DESCRIPTION

A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team diagnosis and treatment, includes radiological, pathological findings and immunohistochemical testing, bridges these gaps across the continuum of care in order to enhance the overall quality of patient-centered general cancer care.   

TARGET AUDIENCE: 

Medical Oncologists, Radiation Oncologists, General Surgeons, Pathologists, Radiologists, Pharmacists, Nurses, Social Workers, Patient Care Facilitators and all personnel involved in the care of the cancer patient. 

LEARNING OBJECTIVES: 

  •  Apply American Joint Commission on Cancer guidelines tumor staging techniques to establish a stage grouping and for optimal treatment plan development.
  •  Develop a comprehensive treatment plan for breast cancer patients leveraging imaging, pathology and immunohistochemical results to meet radiology, pathology, surgery, medical oncology, timeliness of care standards and tumor board documentation standards of practice.  

FACULTY: 

Jessica Buicko Lopez, M.D.

Jessica Buicko Lopez, M.D. director and moderator of this educational activity has no relevant financial relationships with ineligible companies* to disclose and has indicated that the presentations or discussions will not include off-label or unapproved product usage.


Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*


Other contributors involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

 

Disclosure Policy and Disclaimer

ACCREDITATION:

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.    

Baptist Health South Florida designates these live activities for a maximum of 1 AMA PRA Category 1 Credit™. each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

These activities have been approved for 1 credit hours, CE Broker Course #20-710878, by the Florida Boards of Medicine and Osteopathic Medicine.

These activities have also been approved for 1 credits for Nursing, Pharmacy, Respiratory and Social Work. Baptist Health South Florida CE Broker Provider #50-182.
 

image

American Board of Surgery - Maintenance of Certification (MOC) -   Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system. 

Series location: 
Bethesda Hospital Rad/Onc Conference Room, Bethesda Health City, Entrance A
FL
United States

Sessions

Sessionsort ascending Date
Bethesda General Cancer Tumor Board 08/25/2022 - 12:00pm to 1:00pm EDT
Bethesda General Cancer Tumor Board 05/19/2020 - 12:00pm to 1:00pm EDT
Bethesda General Cancer Tumor Board 09/29/2022 - 12:00pm to 1:00pm EDT
Bethesda General Cancer Tumor Board 11/03/2022 - 12:00pm to 1:00pm EDT
Bethesda General Cancer Tumor Board 07/28/2020 - 12:00pm to 1:00pm EDT
Bethesda General Cancer Tumor Board 12/15/2022 - 12:00pm to 1:00pm EST
Bethesda General Cancer Tumor Board 08/25/2020 - 12:00pm to 1:00pm EDT
Bethesda General Cancer Tumor Board 12/29/2022 - 12:00pm to 1:00pm EST
Bethesda General Cancer Tumor Board 09/22/2020 - 12:00pm to 1:00pm EDT
Bethesda General Cancer Tumor Board 01/26/2023 - 12:00pm to 1:00pm EST

Pages